Protara Therapeutics, Inc. · NASDAQ:TARA
Shefferman Jesse sold 215,687 Protara Therapeutics, Inc. shares (Form 4)
Traded Jun 29 to Jun 30, 2026 · Filed Jul 1, 2026
From Jun 29 to Jun 30, 2026, Shefferman Jesse (Director, CEO and President) sold 215,687 Protara Therapeutics, Inc. shares at US$4.09 for US$882K, leaving 691,832 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 215,687 shares
- Price
- US$4.09
- Value
- US$882K
- Holding after
- 691,832 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 215,687 | US$1.91 | 937,519 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 215,687 | US$4.09 | 721,832 | Direct |
| Jun 30, 2026 | Common Stock | Gift | 14,000 | 707,832 | Direct | |
| Jun 30, 2026 | Common Stock | Gift | 7,000 | 700,832 | Direct | |
| Jun 30, 2026 | Common Stock | Gift | 4,000 | 696,832 | Direct | |
| Jun 30, 2026 | Common Stock | Gift | 5,000 | 691,832 | Direct |
Source
Related
- Protara Therapeutics, Inc.
- Shefferman Jesse
- Protara Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026